[1]
İsmet Bulut and Z. Yegin Katran, “Rapid drug desensitization with chemotherapy: when should omalizumab be considered?”, Allergol Immunopathol, vol. 53, no. 4, pp. 21–30, Jul. 2025, doi: 10.15586/aei.v53i4.1349.